Related references
Note: Only part of the references are listed.Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Yelena Y. Janjigian et al.
CANCER DISCOVERY (2018)
A proteomic landscape of diffuse-type gastric cancer
Sai Ge et al.
NATURE COMMUNICATIONS (2018)
Association between PIK3CA alteration and prognosis of gastric cancer patients: a meta-analysis
Hua Li et al.
Oncotarget (2018)
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene
Karol Polom et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers
Soo Young Cho et al.
GASTROENTEROLOGY (2017)
Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
Chie Ito et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer
Joonhong Park et al.
MEDICINE (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients
Yoonjung Kim et al.
ONCOTARGET (2017)
PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
Ji-Won Kim et al.
ONCOTARGET (2017)
Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
C. Boger et al.
ANNALS OF ONCOLOGY (2017)
Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer
Y. Kuboki et al.
ANNALS OF ONCOLOGY (2016)
Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers
Wen-Liang Fang et al.
ONCOTARGET (2016)
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
Kazuto Harada et al.
BMC CANCER (2016)
Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability
Xiangchun Li et al.
CANCER RESEARCH (2016)
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis
E. Bria et al.
SCIENTIFIC REPORTS (2016)
Are PIK3CA Mutation and Amplification Associated with Clinicopathological Characteristics of Gastric Cancer?
Hyunsu Lee et al.
Asian Pacific Journal of Cancer Prevention (2015)
Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis
Xuechao Liu et al.
BMC CANCER (2015)
PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
Ian J. Majewski et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies
Siraj M. Ali et al.
ONCOLOGIST (2015)
Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy
Kexin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer
Maider Ibarrola-Villava et al.
ONCOTARGET (2015)
Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer
Weipeng Lu et al.
MOLECULAR MEDICINE REPORTS (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
HER2 Expression and PI3K-Akt Pathway Alterations in Gastric Cancer
Yasutaka Sukawa et al.
DIGESTION (2014)
Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: Meta-analysis, co-occurrence and ethnic variation
Mei-Ling Chong et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer
Qing-Ying Zhang et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing
Swee Seong Wong et al.
NATURE COMMUNICATIONS (2014)
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status
E. Bria et al.
ANNALS OF ONCOLOGY (2013)
PIK3CA Mutation Is Associated with a Favorable Prognosis among Patients with Curatively Resected Esophageal Squamous Cell Carcinoma
Hironobu Shigaki et al.
CLINICAL CANCER RESEARCH (2013)
Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine
Viktoria S. Warneke et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2013)
Epigenetic Deregulations in Gastric Cancer
Zeeshan Ali et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2013)
Molecular changes in the phosphatidylinositide 3-kinase (PI3K) pathway are common in gastric cancer
Thang N. Tran et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer
Yasutaka Sukawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Oncogenic mutations in gastric cancer with microsatellite instability
Giovanni Corso et al.
EUROPEAN JOURNAL OF CANCER (2011)
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang et al.
NATURE GENETICS (2011)
PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis
Mohammed A. Aleskandarany et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Up-regulation of PIK3CA promotes metastasis in gastric carcinoma
Ji-Fang Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors
Yong Lin et al.
ENDOCRINE-RELATED CANCER (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer et al.
CANCER RESEARCH (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mutation of the PIK3CA oncogene in human cancers
B Karakas et al.
BRITISH JOURNAL OF CANCER (2006)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
Frequent mutation of the PIK3CA gene in ovarian and breast cancers
DA Levine et al.
CLINICAL CANCER RESEARCH (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Share Paper
